Skip to main
ELAN

ELAN Stock Forecast & Price Target

ELAN Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 40%
Buy 50%
Hold 10%
Sell 0%
Strong Sell 0%

Bulls say

Elanco Animal Health is well-positioned for long-term success due to its diversified product portfolio and recent acquisitions of other animal health companies, such as Janssen Animal Health and Novartis Animal Health. The company's seven potential blockbuster launches and strong customer demand for their products are key catalysts for sales growth and margin expansion. Additionally, the company's top position in the Pet Retail market and its resilient demand for protein in the Farm Animal segment make Elanco a strong player in the $40B+ global animal health market.

Bears say

Elanco Animal Health is facing several challenges that could affect its stock price in the future. These include intense competition with other animal health companies, potential failures in research and development efforts, and changing market demand for its products due to disruptive innovation and regulatory restrictions. There is also a risk of negative impact from weather conditions and issues with manufacturing. Even with acquisitions and product launches planned, unfavorable regulatory/pipeline updates and approval of competitor products could further dampen investor confidence and lead to slower sales growth. Additionally, there is a concern about declining market share for certain products, such as flea and worm chewables for dogs, and a decline in the growth rate of the companion animal market. All of these factors could hinder Elanco's ability to achieve its revenue and earnings targets in the future.

ELAN has been analyzed by 10 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 50% recommend Buy, 10% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Elanco Animal Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Elanco Animal Health Inc (ELAN) Forecast

Analysts have given ELAN a Buy based on their latest research and market trends.

According to 10 analysts, ELAN has a Buy consensus rating as of Sep 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $29.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $29.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Elanco Animal Health Inc (ELAN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.